HLA-C expression on platelets: studies with an HLA-Cw1-specific human monoclonal antibody
- PMID: 11054049
- DOI: 10.1159/000031221
HLA-C expression on platelets: studies with an HLA-Cw1-specific human monoclonal antibody
Abstract
Background and objectives: The expression of HLA-C on the surface of platelets is rarely studied due to the lack of proper alloantisera. We addressed this question using an IgM human monoclonal antibody directed against HLA-Cw1 (VP6G3).
Material and methods: Both flow cytometry and complement dependent cytotoxicity studies were used in the current analysis.
Results: The expression of the HLA-Cw1 antigen on platelets is lower than on peripheral blood lymphocytes as shown by flow cytometry. Variation in expression levels between individuals is also observed. Using this antibody in a complement-dependent cytotoxicity assay, we did not observe lysis using platelets as targets, whereas peripheral blood lymphocytes of the same blood donors were adequately lysed.
Conclusions: These results confirm that platelets indeed express HLA-C. Furthermore, the results support the insignificant role of HLA-C in immunological platelet refractoriness.
Copyright 2000 S. Karger AG, Basel
Similar articles
-
A human monoclonal antibody against HLA-Cw1 and a human monoclonal antibody against an HLA-A locus determinant derived from a single uniparous female.Tissue Antigens. 1998 Oct;52(4):393-6. doi: 10.1111/j.1399-0039.1998.tb03062.x. Tissue Antigens. 1998. PMID: 9820605
-
Detection of HLA antigens on blood platelets and lymphocytes by means of monoclonal antibodies in an ELISA technique.Tissue Antigens. 1982 Jan;19(1):11-9. doi: 10.1111/j.1399-0039.1982.tb01411.x. Tissue Antigens. 1982. PMID: 6176045
-
The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.Hum Immunol. 2005 May;66(5):519-25. doi: 10.1016/j.humimm.2005.01.007. Epub 2005 Feb 12. Hum Immunol. 2005. PMID: 15935889
-
Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells.J Stem Cells. 2014;9(3):149-61. J Stem Cells. 2014. PMID: 25157449 Review.
-
[Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].Transfus Clin Biol. 2014 Nov;21(4-5):193-206. doi: 10.1016/j.tracli.2014.08.140. Epub 2014 Sep 30. Transfus Clin Biol. 2014. PMID: 25277423 Review. French.
Cited by
-
Current Status of and Global Trends in Platelet Transfusion Refractoriness From 2004 to 2021: A Bibliometric Analysis.Front Med (Lausanne). 2022 May 6;9:873500. doi: 10.3389/fmed.2022.873500. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35602482 Free PMC article.
-
Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia.Cancer Med. 2020 Jul;9(14):4941-4948. doi: 10.1002/cam4.3140. Epub 2020 May 18. Cancer Med. 2020. PMID: 32419364 Free PMC article.
-
Human Leucocyte Antigen Sensitisation and Its Impact on Transfusion Practice.Transfus Med Hemother. 2019 Oct;46(5):356-369. doi: 10.1159/000502158. Epub 2019 Aug 29. Transfus Med Hemother. 2019. PMID: 31832061 Free PMC article. Review.
-
Recombinant human monoclonal HLA antibodies of different IgG subclasses recognising the same epitope: Excellent tools to study differential effects of donor-specific antibodies.HLA. 2019 Nov;94(5):415-424. doi: 10.1111/tan.13664. Epub 2019 Aug 25. HLA. 2019. PMID: 31403241 Free PMC article.
-
Identification of specificities of antibodies against human leukocyte antigens in blood donors.Transfusion. 2010 Aug;50(8):1749-60. doi: 10.1111/j.1537-2995.2010.02589.x. Epub 2010 Feb 11. Transfusion. 2010. PMID: 20158682 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
